IN THE NEWS: Unpacking the implications of CAR T-cell therapy for patients with multiple myeloma


Abhinav Deol, M.D., hematologist, medical oncologist, and member of the Multiple Myeloma and Amyloidosis, Hematology Oncology and Bone Marrow Stem Cell Transplant Multidisciplinary Teams at Karmanos, gives insight on the future of CAR T-cell therapy and what should be done in order to start reaching new treatment goals.

Read the article here.